In last trading session, Telomir Pharmaceuticals Inc (NASDAQ:TELO) saw 91320.0 shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $4.30 trading at -$0.25 or -5.49% at ring of the bell on the day assigns it a market valuation of $127.93M. That closing price of TELO’s stock is at a discount of -381.86% from its 52-week high price of $20.72 and is indicating a premium of 27.67% from its 52-week low price of $3.11. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.15 million shares which gives us an average trading volume of 172.34K if we extend that period to 3-months.

Telomir Pharmaceuticals Inc (NASDAQ:TELO) trade information

Upright in the red during last session for losing -5.49%, in the last five days TELO remained trading in the green while hitting it’s week-highest on Tuesday, 01/07/25 when the stock touched $4.30 price level, adding 11.52% to its value on the day. Telomir Pharmaceuticals Inc’s shares saw a change of 4.37% in year-to-date performance and have moved 4.37% in past 5-day. Telomir Pharmaceuticals Inc (NASDAQ:TELO) showed a performance of -34.05% in past 30-days. Number of shares sold short was 0.8 million shares which calculate 3.46 days to cover the short interests.

Telomir Pharmaceuticals Inc (TELO) estimates and forecasts

Statistics highlight that Telomir Pharmaceuticals Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 1.18% of value to its shares in past 6 months, showing an annual growth rate of -20.00% while that of industry is 16.70. Apart from that, the company came lowering its revenue forecast for fiscal year 2025.